1. Home
  2. EVC vs ABEO Comparison

EVC vs ABEO Comparison

Compare EVC & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entravision Communications Corporation

EVC

Entravision Communications Corporation

HOLD

Current Price

$3.47

Market Cap

273.8M

Sector

Industrials

ML Signal

HOLD

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$4.86

Market Cap

280.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVC
ABEO
Founded
1996
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
273.8M
280.2M
IPO Year
2000
2005

Fundamental Metrics

Financial Performance
Metric
EVC
ABEO
Price
$3.47
$4.86
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$18.20
AVG Volume (30 Days)
204.4K
928.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
6.62%
N/A
EPS Growth
47.59
38.74
EPS
N/A
1.35
Revenue
$536,034,000.00
$2,998,000.00
Revenue This Year
$64.06
N/A
Revenue Next Year
N/A
$1,589.77
P/E Ratio
N/A
$3.62
Revenue Growth
N/A
258.18
52 Week Low
$1.71
$3.93
52 Week High
$3.44
$7.54

Technical Indicators

Market Signals
Indicator
EVC
ABEO
Relative Strength Index (RSI) 68.04 40.62
Support Level $2.83 $4.87
Resistance Level N/A $5.60
Average True Range (ATR) 0.13 0.19
MACD 0.03 -0.04
Stochastic Oscillator 70.48 17.11

Price Performance

Historical Comparison
EVC
ABEO

About EVC Entravision Communications Corporation

Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: